Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887378 | 0.81 | CES1 (0.39) | CES1PARP1 | |
| SCHEMBL6557292 | 0.81 | GPR84 (0.44) | CES1PARP1 | |
| SCHEMBL29463992 | 0.81 | GPR84 (0.44) | CES1PARP1 | |
| SCHEMBL18965866 | 0.79 | GPR84 (0.42) | CES1PARP1 | |
| SCHEMBL18965964 | 0.79 | GPR84 (0.42) | CES1PARP1 | |
| SCHEMBL6557228 | 0.74 | CES1 (0.39) | CES1PARP1 | |
| SCHEMBL6557449 | 0.73 | CES1 (0.38) | CES1PARP1 | |
| SCHEMBL6557255 | 0.73 | PARP1 (0.39) | CES1PARP1 | |
| SCHEMBL6557223 | 0.73 | CES1 (0.38) | CES1PARP1 | |
| SCHEMBL887350 | 0.72 | PARP1 (0.34) | CES1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | CES1 2520/4885PARP1 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.